Literature DB >> 18192870

Magnetic resonance imaging and magnetic resonance cholangiopancreatography findings compared with fecal elastase 1 measurement for the diagnosis of chronic pancreatitis.

Mehmet Bilgin1, Sabriye Bilgin, N Cem Balci, Amir Javad Momtahen, Yaşar Bilgin, Hans-Ulrich Klör, Wigbert S Rau.   

Abstract

OBJECTIVES: To correlate magnetic resonance cholangiopancreatography (MRCP) and magnetic resonance imaging (MRI) findings of the pancreas with the pancreatic exocrine function determined by fecal elastase 1 concentration.
METHODS: Magnetic resonance imaging and MRCP findings of 81 consecutive patients with clinically suspected chronic pancreatitis and 21 healthy volunteers were evaluated. All subjects underwent MRI/MRCP and fecal elastase 1 testing within 1 to 4 weeks' interval. Magnetic resonance cholangiopancreatography images were evaluated according to Cambridge classification. Magnetic resonance imaging of the pancreas was assessed for pancreatic size, signal, and arterial enhancement.
RESULTS: All volunteers had normal fecal elastase 1 levels (>200 microg/g) and normal MRI/MRCP findings. Thirty-one of 56 patients revealed MRI and/or MRCP findings despite normal fecal elastase 1 concentration. Four of 25 patients revealed normal MRI and MRCP findings despite low fecal elastase 1 concentration (<200 microg/g). Magnetic resonance imaging findings of size (P = 0.00001), arterial enhancement (P = 0.00001), and parenchymal signal (P = 0.001) were significantly different among the control group, patients with normal fecal elastase 1 levels, and patients with low fecal elastase 1 levels. Magnetic resonance cholangiopancreatography findings (P = 0.00001), pancreatic size (P = 0.00001), arterial enhancement (P = 0.014), and parenchymal signal (P = 0.004) on MRI correlated with the fecal elastase 1 concentration.
CONCLUSIONS: Magnetic resonance imaging/MRCP findings correlate with fecal elastase 1 concentration and may precede pancreatic exocrine insufficiency in the early stages of chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18192870     DOI: 10.1097/mpa.0b013e318150e557

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  11 in total

Review 1.  Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.

Authors:  J Enrique Domínguez-Muñoz; Philip D Hardt; Markus M Lerch; Matthias J Löhr
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 2.  Advanced imaging of chronic pancreatitis.

Authors:  Nabil Elia Choueiri; Numan Cem Balci; Samer Alkaade; Frank R Burton
Journal:  Curr Gastroenterol Rep       Date:  2010-04

3.  Diagnostic Performance of Contrast-Enhanced MRI With Secretin-Stimulated MRCP for Non-Calcific Chronic Pancreatitis: A Comparison With Histopathology.

Authors:  Guru Trikudanathan; Sidney P Walker; Satish Munigala; Ben Spilseth; Ahmad Malli; Yusheng Han; Melena Bellin; Srinath Chinnakotla; Ty Dunn; Timothy L Pruett; Gregory J Beilman; Jose Vega Peralta; Mustafa A Arain; Stuart K Amateau; Sarah J Schwarzenberg; Shawn Mallery; Rajeev Attam; Martin L Freeman
Journal:  Am J Gastroenterol       Date:  2015-09-15       Impact factor: 10.864

Review 4.  The role of fecal elastase-1 in detecting exocrine pancreatic disease.

Authors:  John S Leeds; Kofi Oppong; David S Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05-31       Impact factor: 46.802

Review 5.  Diagnosis and treatment of pancreatic exocrine insufficiency.

Authors:  Björn Lindkvist
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

6.  T1 signal intensity ratio of the pancreas as an imaging biomarker for the staging of chronic pancreatitis.

Authors:  Temel Tirkes; Anil K Dasyam; Zarine K Shah; Evan L Fogel; Santhi Swaroop Vege; Liang Li; Shuang Li; Stephanie T Chang; Carlos A Farinas; Joseph R Grajo; Kareem Mawad; Naoki Takahashi; Sudhakar K Venkatesh; Ashley Wachsman; William E Fisher; Christopher E Forsmark; Phil A Hart; Stephen J Pandol; Walter G Park; Stephen K Van Den Eeden; Yunlong Yang; Mark Topazian; Dana K Andersen; Jose Serrano; Darwin L Conwell; Dhiraj Yadav
Journal:  Abdom Radiol (NY)       Date:  2022-07-20

7.  Histopathologic correlation of pancreatic fibrosis with pancreatic magnetic resonance imaging quantitative metrics and Cambridge classification.

Authors:  Temel Tirkes; Omer A Saeed; Vitalis C Osuji; Carsyn E Kranz; Adam A Roth; Aashish A Patel; Nicholas J Zyromski; Evan L Fogel
Journal:  Abdom Radiol (NY)       Date:  2022-04-29

8.  Association of faecal elastase 1 with non-fasting triglycerides in type 2 diabetes.

Authors:  Wolfgang Rathmann; Burkhard Haastert; Jan Oscarsson; Niklas Berglind; Björn Lindkvist; Nicholas J Wareham
Journal:  Pancreatology       Date:  2016-03-30       Impact factor: 3.996

Review 9.  Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines.

Authors:  Mary E Phillips; Andrew D Hopper; John S Leeds; Keith J Roberts; Laura McGeeney; Sinead N Duggan; Rajesh Kumar
Journal:  BMJ Open Gastroenterol       Date:  2021-06

10.  Overhauser-enhanced MRI of elastase activity from in vitro human neutrophil degranulation.

Authors:  Elodie Parzy; Véronique Bouchaud; Philippe Massot; Pierre Voisin; Neha Koonjoo; Damien Moncelet; Jean-Michel Franconi; Eric Thiaudière; Philippe Mellet
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.